1st Quarter - Amendment
CHAMBER HILL STRATEGIES for AMAG PHARMACEUTICALS (FORMERLY KNOWN AS LUMARA PHARMACEUTICAL)
Income
$60,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 14, 2014 | $40,000 | Replaced |
| 1st Quarter - Amendment (this page) | Jul 23, 2014 | $60,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Implementation issues related to P.L. 113-54, the Drug Quality and Security Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER BELL | Legislative Assistant, Rep. John Thune (R-SD) |
| ADAM ETZION | — |
| JENNIFER HIGGINS New | — |
| MICHAELA SIMS | Legislative Counsel, Sen. Bob Kerrey |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.